About Gregor Diagnostics
Gregor Diagnostics is a company based in Madison (United States) founded in 2016.. Gregor Diagnostics has raised $10.49 million across 8 funding rounds from investors including Gener8tor, First Round Capital and Green Park & Golf Ventures. Gregor Diagnostics offers products and services including Reflex 1+ Genomic classifier, Reflex 2+ Genomic classifier, and Active Surveillance Genomic classifier. Gregor Diagnostics operates in a competitive market with competitors including Guardant Health, GRAIL, Thrive Earlier Detection, Delfi Diagnostics and BillionToOne, among others.
- Headquarter Madison, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gregor Diagnostics Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.49 M (USD)
in 8 rounds
-
Latest Funding Round
$242.03 K (USD), Series A
Oct 20, 2025
-
Investors
Gener8tor
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gregor Diagnostics
Gregor Diagnostics offers a comprehensive portfolio of products and services, including Reflex 1+ Genomic classifier, Reflex 2+ Genomic classifier, and Active Surveillance Genomic classifier. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects prostate cancer before biopsy to prevent overdiagnosis.
Distinguishes benign from serious cancers for treatment decisions.
Monitors prostate cancer in patients on active surveillance programs.
Unlock access to complete
Unlock access to complete
Funding Insights of Gregor Diagnostics
Gregor Diagnostics has successfully raised a total of $10.49M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $242.03 thousand completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $242,034
-
First Round
First Round
(01 Jun 2016)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series A - Gregor Diagnostics | Valuation |
investors |
|
| Nov, 2023 | Amount | Debt – Conventional - Gregor Diagnostics | Valuation |
investors |
|
| Mar, 2023 | Amount | Series A - Gregor Diagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gregor Diagnostics
Gregor Diagnostics has secured backing from 7 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Gener8tor, First Round Capital and Green Park & Golf Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused seed and early-stage VC firm
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investments are made in medical startups.
|
Founded Year | Domain | Location | |
|
Healthcare startups are accelerated via a 12-week funding program.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gregor Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Gregor Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gregor Diagnostics Comparisons
Competitors of Gregor Diagnostics
Gregor Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Thrive Earlier Detection, Delfi Diagnostics and BillionToOne, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
|
| domain | founded_year | HQ Location |
Non-invasive blood tests for prenatal fetal health predictions are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gregor Diagnostics
Frequently Asked Questions about Gregor Diagnostics
When was Gregor Diagnostics founded?
Gregor Diagnostics was founded in 2016.
Where is Gregor Diagnostics located?
Gregor Diagnostics is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Who is the current CEO of Gregor Diagnostics?
Steven Weinstein is the current CEO of Gregor Diagnostics.
Is Gregor Diagnostics a funded company?
Gregor Diagnostics is a funded company, having raised a total of $10.49M across 8 funding rounds to date. The company's 1st funding round was a Series A of $7.43M, raised on Jun 01, 2016.
What does Gregor Diagnostics do?
Gregor Diagnostics was founded in 2016 in Madison, United States, within the healthcare diagnostics sector. A proprietary assay is utilized to analyze seminal fluid for eight cancer-associated biomarkers, which may not be detected in blood or urine tests. Patients are stratified into categories of no cancer, indolent cancer, or aggressive cancer. At-home sample collection kits are sent to the company for processing and results.
Who are the top competitors of Gregor Diagnostics?
Gregor Diagnostics's top competitors include Guardant Health, GRAIL and BillionToOne.
What products or services does Gregor Diagnostics offer?
Gregor Diagnostics offers Reflex 1+ Genomic classifier, Reflex 2+ Genomic classifier, and Active Surveillance Genomic classifier.
Who are Gregor Diagnostics's investors?
Gregor Diagnostics has 7 investors. Key investors include Gener8tor, First Round Capital, Green Park & Golf Ventures, Nat Turner, and Zach Weinberg.